Skip to main content

Fiscal Wizard · Single-issue tearsheet

CAH / Jun 22, 2026 Run #7598

CAH

Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Composite verdict

B 70.3 / 100
Bullish setup · Trend Following 17 drivers · 2 gates blocking
  • Fibonacci Retracement
  • Rate of Change
  • Accumulation/Distribution Line
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 2nd of 12 in Medical Distribution

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 22 signals0% Bear
Momentum Bullish 98Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from
Asset value $-11.87Earnings power value $63.08Price $221.77

Priced above its no-growth earnings power value ($63.08/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

40.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
OCF to Net Income 0
Greenblatt ROC 100
Total Shareholder Yield 0
Cash Conversion Cycle 99
Earnings Yield 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Fibonacci Retracement, Rate of Change, Accumulation/Distribution Line); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Rate of Change 89
Accumulation/Distribution Line 87
Fibonacci Retracement 84

Risk Gates

2 blocking 9 caution

2 guards active, 18 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Beneish M-Score Caution

Bottom-band Beneish M blocks bullish signals — accounting-quality risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CAH.